These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 27304190)
1. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance. Breslin S; O'Driscoll L Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491 [TBL] [Abstract][Full Text] [Related]
3. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems. Howes AL; Richardson RD; Finlay D; Vuori K PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711 [TBL] [Abstract][Full Text] [Related]
4. 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response. Gangadhara S; Smith C; Barrett-Lee P; Hiscox S BMC Cancer; 2016 Jun; 16():345. PubMed ID: 27251376 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and Antiproliferative Effects of Preussin, a Hydroxypyrrolidine Derivative from the Marine Sponge-Associated Fungus Malhão F; Ramos AA; Buttachon S; Dethoup T; Kijjoa A; Rocha E Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31366127 [TBL] [Abstract][Full Text] [Related]
6. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide. Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328 [TBL] [Abstract][Full Text] [Related]
7. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines. Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture. Alwahsh M; Al-Doridee A; Jasim S; Awwad O; Hergenröder R; Hamadneh L Mol Biol Rep; 2024 Jun; 51(1):721. PubMed ID: 38829450 [TBL] [Abstract][Full Text] [Related]
9. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures. Mosaad E; Chambers K; Futrega K; Clements J; Doran MR BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440 [TBL] [Abstract][Full Text] [Related]
10. Cancer cells growing on perfused 3D collagen model produced higher reactive oxygen species level and were more resistant to cisplatin compared to the 2D model. Liu Q; Zhang Z; Liu Y; Cui Z; Zhang T; Li Z; Ma W J Appl Biomater Funct Mater; 2018 Jul; 16(3):144-150. PubMed ID: 29609492 [TBL] [Abstract][Full Text] [Related]
11. Silicate fiber-based 3D cell culture system for anticancer drug screening. Yamaguchi Y; Deng D; Sato Y; Hou YT; Watanabe R; Sasaki K; Kawabe M; Hirano E; Morinaga T Anticancer Res; 2013 Dec; 33(12):5301-9. PubMed ID: 24324063 [TBL] [Abstract][Full Text] [Related]
12. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles. Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378 [TBL] [Abstract][Full Text] [Related]
13. Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening. Kraniak JM; Chalasani A; Wallace MR; Mattingly RR Exp Neurol; 2018 Jan; 299(Pt B):289-298. PubMed ID: 29055717 [TBL] [Abstract][Full Text] [Related]
14. Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile. Nunes AS; Costa EC; Barros AS; de Melo-Diogo D; Correia IJ Biotechnol J; 2019 Apr; 14(4):e1800268. PubMed ID: 30242980 [TBL] [Abstract][Full Text] [Related]
15. 3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture. Tatara T; Mukohara T; Tanaka R; Shimono Y; Funakoshi Y; Imamura Y; Toyoda M; Kiyota N; Hirai M; Kakeji Y; Minami H Anticancer Res; 2018 May; 38(5):2831-2839. PubMed ID: 29715106 [TBL] [Abstract][Full Text] [Related]
16. High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. Hongisto V; Jernström S; Fey V; Mpindi JP; Kleivi Sahlberg K; Kallioniemi O; Perälä M PLoS One; 2013; 8(10):e77232. PubMed ID: 24194875 [TBL] [Abstract][Full Text] [Related]
17. 3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer. Chambers KF; Mosaad EM; Russell PJ; Clements JA; Doran MR PLoS One; 2014; 9(11):e111029. PubMed ID: 25380249 [TBL] [Abstract][Full Text] [Related]
18. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability. Kulesza J; Pawłowska M; Augustin E Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841 [TBL] [Abstract][Full Text] [Related]
19. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment. Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018 [TBL] [Abstract][Full Text] [Related]
20. Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response. Souza AG; Silva IBB; Campos-Fernandez E; Barcelos LS; Souza JB; Marangoni K; Goulart LR; Alonso-Goulart V Curr Pharm Des; 2018; 24(15):1689-1694. PubMed ID: 29623827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]